Non-Δ 9tetrahydrocannabinol phytocannabinoids stimulate feeding in rats

Behavioural Pharmacology

Volumn 23, Issue 1, 2012, Pages 113-117

  Farrimond, Jonathan A ^a   Whalley, Benjamin J ^a   Williams, Claire M ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

9tetrahydrocannabinol; appetite; appetitive; behaviour; consummatory; feeding; hyperphagia; phytocannabinoid; rat

Indexed keywords

CANNABIS; TETRAHYDROCANNABINOL; TETRAHYDROCANNABINOL DERIVATIVE;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEEDING BEHAVIOR; NONHUMAN; POST HOC ANALYSIS; RAT; SATIETY;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; MALE; PLANT EXTRACTS; RATS; TETRAHYDROCANNABINOL;

EID: 84855695243     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0b013e32834ed832     Document Type: Article

References (25)

1. Devane W, Dysarz F, Johnson MR, Melvin LS, Howlett A (1988). Determination and characterisation of a cannabinoid receptor in the rat brain. Mol Pharmacol 34:605-613. (Pubitemid 19007296)
2. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, et al. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949. (Pubitemid 23026736)
3. Di Marzo V, De Petrocellis L, Bisogno T (2005). The biosynthesis, fate and pharmacological properties of endocannabinoids. Handb Exp Pharmacol 168:147-185.
4. Farrimond J, Hill A, Whalley B, Williams C (2010a). Cannabis constituents modulate 9-tetrahydrocannabinol-induced hyperphagia in rats. Psychophar-macology 210:97-106.
5. Farrimond JA, Whalley BJ, Williams CM (2010b). A low D9tetrahydrocannabinol cannabis extract induces hyperphagia in rats. Behav Pharmacol 21:769-773.
6. Farrimond JA, Mercier MS, Whalley BJ, Williams CM (2011). Cannabis sativa and the endogenous cannabinoid system: therapeutic potential for appetite regulation. Phytother Res 25:18.
7. Felder CC, Joyce KE, Briley EM, Mansouri J, Mackie K, Blond O, et al. (1995). Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol 48:443-450.
8. Gaoni Y, Mechoulam R (1964). Isolation, structure, and partial synthesis of an active constituent of Hashish. J Am Chem Soc 86:1646-1647.
9. Ignatowska-Jankowska B, Jankowski M, Swiergiel A (2010). Cannabidiol decreases body weight gain in rats: involvement of CB2 receptors. Neurosci Lett 490:82-84.
10. Izzo AA, Borrelli F, Capasso R, Di Marzo V, Mechoulam R (2009). Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci 30:515-527.
11. Lozovaya N, Min R, Tsintsadze V, Burnashev N (2009). Dual modulation of CNS voltage-gated calcium channels by cannabinoids: Focus on CB1 receptor-independent effects. Cell Calcium 46:154-162.
12. Martin BR, Balster RL, Razdan RK, Harris LS, Dewey WL (1981). Behavioral comparisons of the stereoisomers of tetrahydrocannabinols. Life Sci 29:565-574. (Pubitemid 11030909)
13. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564.
14. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, et al. (1995). Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50:83-90.
15. Munro S, Thomas KL, Abu-Shaar M (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61-65. (Pubitemid 23305569)
16. Pertwee RG (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: D9-tetrahydrocannabinol, cannabidiol and D9-tetrahydro-cannabivarin. Br J Pharmacol 153:199-215.
17. Potter DJ, Clark P, Brown MB (2008). Potency of D9-THC and other cannabinoids in Cannabis in England in 2005: implications for psychoactivity and pharmacology. J Forensic Sci 53:90-94. (Pubitemid 351239216)
18. Rhee MH, Vogel Z, Barg J, Bayewitch M, Levy R, Hanus L, et al. (1997). Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase. J Med Chem 40:3228-3233. (Pubitemid 27413747)
19. Riedel G, Fadda P, McKillop-Smith S, Pertwee R, Platt B, Robinson L (2009). Synthetic and plant-derived cannabinoid receptor antagonists show hypopha-gic properties in fasted and non-fasted mice. Br J Pharmacol 156:1154-1166.
20. Sofia RD, Knobloch LC (1976). Comparative effects of various naturally occurring cannabinoids on food, sucrose and water consumption by rats. Pharmacol Biochem Behav 4:591-599.
21. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, et al. (1995). 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215:89-97.
22. Williams CM, Kirkham TC (1999). Anandamide induces overeating: mediation by central cannabinoid CB1 receptors. Psychopharmacology 143:315-317. (Pubitemid 29204987)
23. Williams CM, Kirkham TC (2002a). Observational analysis of feeding induced by Delta9-THC and anandamide. Physiol Behav 76:241-250. (Pubitemid 34607232)
24. Williams CM, Kirkham TC (2002b). Reversal of D9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine. Pharmacol Biochem Behav 71:333-340.
25. Williams CM, Rogers PJ, Kirkham TC (1998). Hyperphagia in pre-fed rats following oral D9-THC. Physiol Behav 65:343-346. (Pubitemid 28548657)